| Acute Coronary Syndrome |
1 |
1 |
| Thromboembolism |
0 |
0.82 |
| Aspirin |
0 |
0.74 |
| Cardiac Surgery |
0 |
0.48 |
| Cerebrovascular Accident |
0 |
0.46 |
| Percutaneous Coronary Intervention |
0 |
0.39 |
| Hemodialysis |
0 |
0.34 |
| Dialysis |
0 |
0.21 |
| Oklahoma |
0 |
0.21 |
| Antithrombotics |
0 |
0.18 |
| Coronary Artery Bypass Graft (CABG) |
0 |
0.18 |
| Cardiovascular Imaging |
0 |
0.17 |
| Healthcare and Medical Technology |
0 |
0.17 |
| Neuroendocrine Tumor |
0 |
0.17 |
| Cardiac Catheterization |
0 |
0.15 |
| Angiography |
0 |
0.11 |
| Anticoagulation Therapy |
0 |
0.11 |
| Antiplatelet Agent |
0 |
0.11 |
| Artery |
0 |
0.11 |
| Catheterization |
0 |
0.11 |
| Clinical Guidelines |
0 |
0.11 |
| Clinical Research |
0 |
0.11 |
| Graft |
0 |
0.11 |
| Hemorrhage |
0 |
0.11 |
| Interventional Cardiology |
0 |
0.11 |
| Ischemia |
0 |
0.11 |
| Liver |
0 |
0.11 |
| Restenosis |
0 |
0.11 |
| Stent |
0 |
0.11 |
| Target Lesion Revascularization |
0 |
0.11 |
| Target Vessel Revascularization |
0 |
0.11 |
| Thrombosis |
0 |
0.11 |
| Washington |
0 |
0.11 |